Given that activation of cGAS–STING and TLR9 pathways by cfDNA contributes to maladaptive remodeling and adverse outcomes after MI, these ASO-based strategies represent a mechanistically targeted approach to mitigating inflammation-driven progression to HF. This evidence concerns the gene TLR9 and hydrops fetalis.